Real-world Experience With Lutetium Vipivotide Tetraxetan in Metastatic Castration Resistant Prostate Cancer
Clinical trial NCT06517719 · RECRUITING
Trial details
- NCT number
- NCT06517719
- Sponsor
- Novartis Pharmaceuticals
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-09-04
- Primary completion
- 2028-02-01
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.